[PHARMA] QoQ TTM Result on 30-Jun-2014 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 17.85%
YoY- 39.22%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 2,126,165 2,122,933 2,063,690 2,002,411 1,914,972 1,946,639 1,861,183 9.28%
PBT 126,033 125,580 120,733 109,249 94,232 92,997 64,238 56.78%
Tax -26,528 -31,355 -41,862 -41,209 -35,978 -36,236 -36,212 -18.75%
NP 99,505 94,225 78,871 68,040 58,254 56,761 28,026 132.91%
-
NP to SH 99,421 93,844 77,960 66,756 56,646 55,200 26,453 141.92%
-
Tax Rate 21.05% 24.97% 34.67% 37.72% 38.18% 38.96% 56.37% -
Total Cost 2,026,660 2,028,708 1,984,819 1,934,371 1,856,718 1,889,878 1,833,157 6.92%
-
Net Worth 528,173 525,351 507,124 502,293 515,022 486,672 473,402 7.57%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div 80,234 72,463 57,457 44,519 42,973 41,446 37,168 67.10%
Div Payout % 80.70% 77.22% 73.70% 66.69% 75.86% 75.08% 140.51% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 528,173 525,351 507,124 502,293 515,022 486,672 473,402 7.57%
NOSH 258,908 258,794 258,737 258,914 258,805 258,868 258,689 0.05%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 4.68% 4.44% 3.82% 3.40% 3.04% 2.92% 1.51% -
ROE 18.82% 17.86% 15.37% 13.29% 11.00% 11.34% 5.59% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 821.20 820.32 797.60 773.39 739.93 751.98 719.47 9.22%
EPS 38.40 36.26 30.13 25.78 21.89 21.32 10.23 141.72%
DPS 31.00 28.00 22.20 17.20 16.61 16.01 14.37 67.03%
NAPS 2.04 2.03 1.96 1.94 1.99 1.88 1.83 7.51%
Adjusted Per Share Value based on latest NOSH - 258,914
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 147.52 147.30 143.19 138.94 132.87 135.07 129.14 9.28%
EPS 6.90 6.51 5.41 4.63 3.93 3.83 1.84 141.56%
DPS 5.57 5.03 3.99 3.09 2.98 2.88 2.58 67.11%
NAPS 0.3665 0.3645 0.3519 0.3485 0.3573 0.3377 0.3285 7.57%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 6.00 4.58 4.63 4.61 4.46 4.45 4.82 -
P/RPS 0.73 0.56 0.58 0.60 0.60 0.59 0.67 5.88%
P/EPS 15.62 12.63 15.37 17.88 20.38 20.87 47.14 -52.14%
EY 6.40 7.92 6.51 5.59 4.91 4.79 2.12 109.02%
DY 5.17 6.11 4.79 3.73 3.72 3.60 2.98 44.43%
P/NAPS 2.94 2.26 2.36 2.38 2.24 2.37 2.63 7.71%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 -
Price 6.91 5.28 4.45 4.62 4.70 4.29 4.72 -
P/RPS 0.84 0.64 0.56 0.60 0.64 0.57 0.66 17.45%
P/EPS 17.99 14.56 14.77 17.92 21.47 20.12 46.16 -46.67%
EY 5.56 6.87 6.77 5.58 4.66 4.97 2.17 87.35%
DY 4.49 5.30 4.99 3.72 3.53 3.73 3.04 29.72%
P/NAPS 3.39 2.60 2.27 2.38 2.36 2.28 2.58 19.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment